Clinical Trial Update: A Study of EP0031 in Patients With Advanced RET-altered Malignancies [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial update for EP0031 in patients with advanced RET-altered malignancies, including non-small cell lung cancer, which is currently recrui…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• EP0031

Snippet

Sponsor: Ellipses Pharma | Conditions: Advanced Solid Tumor, NSCLC | Phase 1, Phase 2 | Status: RECRUITING